US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

1.38

-0.0700-4.83%

Post-market: 1.390.0100+0.72%19:34 EDT

Volume:6.70M

Turnover:9.31M

Market Cap:389.16M

PE:-4.53

High:1.48

Open:1.47

Low:1.37

Close:1.45

52wk High:3.07

52wk Low:0.4600

Shares:282.00M

Float Shares:204.00M

Volume Ratio:2.37

T/O Rate:3.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3048

EPS(LYR):-0.3048

ROE:-33.96%

ROA:-17.09%

PB:1.61

PE(LYR):-4.53

Loading ...

Overview Company News Filings

Invivyd reports cash, cash equivalents of $226.7M as of December 31

Invivyd appoints Michael Mina as CMO

Invivyd FY revenue rises; operating expenses cut sharply

BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39

Invivyd Q4 net product revenue rises 31% to USD 17.2 million in Q4 2025 earnings

Invivyd Names Michael Mina Chief Medical Officer

Invivyd FY Net Income USD -52.489 Million VS. Ibes Estimate USD -57.8 Million

THOMSON REUTERS

Press Release: Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates

Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer

Invivyd Inc expected to post a loss of 8 cents a share - Earnings Preview

Invivyd Grants 192,000 Inducement Stock Options to New Hires

Invivyd Price Target Maintained With a $10.00/Share by BTIG

Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and Invivyd (IVVD)

Invivyd Study Links Pemivibart Serum Levels to Variant-Agnostic COVID-19 Protection

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)

Invivyd Reaches Alignment With US FDA on Phase 3 Trial of VYD2311 for COVID Prevention

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney

BUZZ-Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines

Invivyd Aligns With the U.S. FDA on Liberty, a Phase 3 Trial to Evaluate the Safety of Vyd2311 Antibody Versus Mrna Covid Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration

THOMSON REUTERS

Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them.

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IVVD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVVD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","market":"US","secType":"STK","nameCN":"Invivyd, Inc.","latestPrice":1.38,"timestamp":1774036800000,"preClose":1.45,"halted":0,"volume":6698513,"hourTrading":{"tag":"盘后","latestPrice":1.39,"preClose":1.38,"latestTime":"19:34 EDT","volume":2203575,"amount":3040763.9094,"timestamp":1774049678343,"change":0.01,"changeRate":0.007246,"amplitude":0.021739},"delay":0,"changeRate":-0.04827586206896556,"floatShares":204000000,"shares":282000000,"eps":-0.304791,"marketStatus":"Market Closed","change":-0.07,"latestTime":"03-20 16:00:00 EDT","open":1.47,"high":1.475,"low":1.37,"amount":9307076.7360659,"amplitude":0.072414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.304791,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774252800000},"marketStatusCode":7,"adr":0,"listingDate":1628222400000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.46,"preClose":1.45,"latestTime":"09:29 EDT","volume":3658,"amount":5335.6451288,"timestamp":1774013370023,"change":0.01,"changeRate":0.006897,"amplitude":0.034483},"postHourTrading":{"tag":"盘后","latestPrice":1.39,"preClose":1.38,"latestTime":"19:34 EDT","volume":2203575,"amount":3040763.9094,"timestamp":1774049678343,"change":0.01,"changeRate":0.007246,"amplitude":0.021739},"volumeRatio":2.3713299001392647,"impliedVol":0.8504,"impliedVolPercentile":0.2351},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVVD\",,,,,undefined,":{"symbol":"IVVD","floatShares":204000000,"roa":"-17.09%","roe":"-33.96%","lyrEps":-0.304791,"volumeRatio":2.3713299001392647,"shares":282000000,"dividePrice":0,"high":1.475,"amplitude":0.072414,"preClose":1.45,"low":1.37,"week52Low":0.46,"pbRate":"1.61","psRate":"7.28","week52High":3.0699,"institutionHeld":0,"latestPrice":1.38,"eps":-0.304791,"divideRate":0,"volume":6698513,"delay":0,"ttmEps":-0.304791,"open":1.47,"prevYearClose":2.47,"prevWeekClose":1.74,"prevMonthClose":1.69,"prevQuarterClose":2.47,"fiveDayClose":1.74,"twentyDayClose":1.55,"sixtyDayClose":2.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVVD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"IVVD","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"pre","actualEps":0},{"date":"2026-01-08","symbol":"IVVD","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1767862800000,"name":null,"time":"Pre-Market","dateTimestamp":1767848400000,"actualEps":null},{"market":"US","date":"2025-11-06","symbol":"IVVD","fiscalQuarterEnding":"2025/09","expectedEps":-0.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.06},{"market":"US","date":"2025-08-14","symbol":"IVVD","fiscalQuarterEnding":"2025/06","expectedEps":-0.04,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IVVD","fiscalQuarterEnding":"2025/03","expectedEps":-0.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVVD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVVD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1766462400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVVD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVVD","date":"2026-03-20","current":-4.527693,"percent":0.14248,"low":-54.35026,"twenty":-3.448726,"median":-1.124676,"eighty":-0.615376,"high":-0.170743,"avg":-4.178681,"sd":8.362099,"marketCap":409762357},"quantilePoints":[{"date":"2021-08-06","current":-20.235974,"twenty":-12.209882,"median":-0.170743,"eighty":-0.170743,"marketCap":2265932260},{"date":"2021-08-13","current":-25.837695,"twenty":-26.477338,"median":-22.901153,"eighty":-8.196835,"marketCap":2893187455},{"date":"2021-08-20","current":-26.787468,"twenty":-26.857247,"median":-25.973377,"eighty":-21.081078,"marketCap":2999538682},{"date":"2021-08-27","current":-29.442955,"twenty":-27.834156,"median":-26.254432,"eighty":-22.790669,"marketCap":3296888030},{"date":"2021-09-03","current":-41.082517,"twenty":-30.582682,"median":-26.903767,"eighty":-24.407221,"marketCap":4600233167},{"date":"2021-09-10","current":-52.237501,"twenty":-34.346884,"median":-27.107289,"eighty":-25.864831,"marketCap":5849317474},{"date":"2021-09-17","current":-49.87276,"twenty":-41.574848,"median":-28.333272,"eighty":-25.990822,"marketCap":5584524623},{"date":"2021-09-24","current":-43.437403,"twenty":-45.837563,"median":-31.3425,"eighty":-26.070293,"marketCap":4863922575},{"date":"2021-10-01","current":-27.799143,"twenty":-45.332177,"median":-32.752622,"eighty":-26.167208,"marketCap":3112821446},{"date":"2021-10-08","current":-34.098162,"twenty":-44.772716,"median":-31.663999,"eighty":-26.477338,"marketCap":3818156971},{"date":"2021-10-15","current":-32.220379,"twenty":-44.391197,"median":-31.942189,"eighty":-26.810728,"marketCap":3607891333},{"date":"2021-10-22","current":-33.531847,"twenty":-43.143316,"median":-32.796234,"eighty":-26.944471,"marketCap":3754743525},{"date":"2021-10-29","current":-29.050998,"twenty":-41.908316,"median":-32.394248,"eighty":-27.107289,"marketCap":3252998538},{"date":"2021-11-05","current":-19.910465,"twenty":-41.574848,"median":-31.842835,"eighty":-27.107289,"marketCap":2229483266},{"date":"2021-11-12","current":-19.016283,"twenty":-41.160049,"median":-31.463508,"eighty":-26.167208,"marketCap":2129356772},{"date":"2021-11-19","current":-10.754495,"twenty":-40.958465,"median":-30.898976,"eighty":-23.930397,"marketCap":2232820816},{"date":"2021-11-26","current":-13.460534,"twenty":-40.462257,"median":-30.670462,"eighty":-19.910465,"marketCap":2794641699},{"date":"2021-12-03","current":-24.557973,"twenty":-40.277958,"median":-30.278016,"eighty":-20.235974,"marketCap":5098663577},{"date":"2021-12-10","current":-17.806272,"twenty":-39.274486,"median":-29.442955,"eighty":-19.910465,"marketCap":3696892661},{"date":"2021-12-17","current":-6.15155,"twenty":-36.830387,"median":-28.396375,"eighty":-19.016283,"marketCap":1277169056},{"date":"2021-12-23","current":-4.640455,"twenty":-35.773265,"median":-28.318734,"eighty":-17.731253,"marketCap":963439375},{"date":"2021-12-31","current":-3.890266,"twenty":-34.889434,"median":-27.107289,"eighty":-10.888458,"marketCap":807687051},{"date":"2022-01-07","current":-3.177586,"twenty":-34.726181,"median":-26.845617,"eighty":-10.250797,"marketCap":659722343},{"date":"2022-01-14","current":-3.054341,"twenty":-34.716142,"median":-26.109059,"eighty":-6.024018,"marketCap":634134462},{"date":"2022-01-21","current":-3.370492,"twenty":-34.344559,"median":-25.973377,"eighty":-4.803353,"marketCap":699772941},{"date":"2022-01-28","current":-3.633058,"twenty":-33.758373,"median":-25.150086,"eighty":-4.146402,"marketCap":754286254},{"date":"2022-02-04","current":-4.41004,"twenty":-33.472235,"median":-24.833935,"eighty":-4.117466,"marketCap":915601161},{"date":"2022-02-11","current":-3.750945,"twenty":-33.414609,"median":-22.901153,"eighty":-4.037089,"marketCap":778761620},{"date":"2022-02-18","current":-3.440152,"twenty":-33.038815,"median":-20.249744,"eighty":-3.881692,"marketCap":714235657},{"date":"2022-02-25","current":-3.499096,"twenty":-32.761344,"median":-19.910465,"eighty":-3.803458,"marketCap":726473339},{"date":"2022-03-04","current":-2.695322,"twenty":-32.644704,"median":-19.383891,"eighty":-3.620198,"marketCap":559595849},{"date":"2022-03-11","current":-2.706039,"twenty":-32.425048,"median":-19.016283,"eighty":-3.495881,"marketCap":561820883},{"date":"2022-03-18","current":-2.663171,"twenty":-32.232302,"median":-18.082234,"eighty":-3.447654,"marketCap":552920750},{"date":"2022-03-25","current":-2.121963,"twenty":-32.069361,"median":-13.460534,"eighty":-3.399428,"marketCap":440556573},{"date":"2022-04-01","current":-2.185863,"twenty":-31.771301,"median":-10.864345,"eighty":-3.292258,"marketCap":495731781},{"date":"2022-04-08","current":-1.866688,"twenty":-31.632206,"median":-10.454419,"eighty":-3.196877,"marketCap":423346167},{"date":"2022-04-14","current":-1.736117,"twenty":-31.536113,"median":-10.036457,"eighty":-2.990039,"marketCap":393733871},{"date":"2022-04-22","current":-1.426614,"twenty":-31.313407,"median":-6.874947,"eighty":-2.80142,"marketCap":323541760},{"date":"2022-04-29","current":-1.38309,"twenty":-31.137425,"median":-5.513889,"eighty":-2.691035,"marketCap":313670994},{"date":"2022-05-06","current":-1.392762,"twenty":-30.873144,"median":-5.106644,"eighty":-2.665314,"marketCap":315864498},{"date":"2022-05-13","current":-1.033486,"twenty":-30.749945,"median":-4.774417,"eighty":-2.440927,"marketCap":298425270},{"date":"2022-05-20","current":-1.120876,"twenty":-30.64463,"median":-4.321625,"eighty":-2.212136,"marketCap":323659760},{"date":"2022-05-27","current":-1.132275,"twenty":-30.523419,"median":-4.206417,"eighty":-2.074048,"marketCap":326951215},{"date":"2022-06-03","current":-1.200668,"twenty":-30.451885,"median":-4.15819,"eighty":-1.963408,"marketCap":346699946},{"date":"2022-06-10","current":-1.124676,"twenty":-30.104147,"median":-3.970643,"eighty":-1.784476,"marketCap":324756912},{"date":"2022-06-17","current":-1.033486,"twenty":-30.05447,"median":-3.890266,"eighty":-1.562021,"marketCap":298425270},{"date":"2022-06-24","current":-1.27695,"twenty":-29.565258,"median":-3.847398,"eighty":-1.481744,"marketCap":368726981},{"date":"2022-07-01","current":-1.330156,"twenty":-29.129389,"median":-3.775058,"eighty":-1.43822,"marketCap":384090605},{"date":"2022-07-08","current":-1.569584,"twenty":-28.687364,"median":-3.66253,"eighty":-1.432587,"marketCap":453226914},{"date":"2022-07-15","current":-1.527779,"twenty":-28.386662,"median":-3.584832,"eighty":-1.439301,"marketCap":441155495},{"date":"2022-07-22","current":-1.580986,"twenty":-28.330364,"median":-3.496417,"eighty":-1.441122,"marketCap":456519119},{"date":"2022-07-29","current":-1.337757,"twenty":-28.318734,"median":-3.466945,"eighty":-1.439301,"marketCap":386285408},{"date":"2022-08-05","current":-1.520179,"twenty":-28.006979,"median":-3.442832,"eighty":-1.418008,"marketCap":438960692},{"date":"2022-08-12","current":-1.516378,"twenty":-27.384031,"median":-3.402643,"eighty":-1.425167,"marketCap":437863290},{"date":"2022-08-19","current":-1.549068,"twenty":-27.107289,"median":-3.34102,"eighty":-1.426035,"marketCap":457088205},{"date":"2022-08-26","current":-1.69291,"twenty":-26.985176,"median":-3.279398,"eighty":-1.431485,"marketCap":499532109},{"date":"2022-09-02","current":-1.762987,"twenty":-26.833988,"median":-3.247247,"eighty":-1.435834,"marketCap":520209909},{"date":"2022-09-09","current":-1.696599,"twenty":-26.632403,"median":-3.150793,"eighty":-1.43839,"marketCap":500620415},{"date":"2022-09-16","current":-1.416291,"twenty":-26.283507,"median":-2.973964,"eighty":-1.43839,"marketCap":417909216},{"date":"2022-09-23","current":-1.095413,"twenty":-26.089676,"median":-2.842681,"eighty":-1.425167,"marketCap":323226659},{"date":"2022-09-30","current":-1.166035,"twenty":-26.025711,"median":-2.786416,"eighty":-1.403926,"marketCap":344065403},{"date":"2022-10-07","current":-1.188387,"twenty":-25.919104,"median":-2.692642,"eighty":-1.367291,"marketCap":350660906},{"date":"2022-10-14","current":-1.221915,"twenty":-25.585157,"median":-2.679246,"eighty":-1.335295,"marketCap":360554160},{"date":"2022-10-21","current":-1.370929,"twenty":-25.161339,"median":-2.598869,"eighty":-1.327097,"marketCap":404524180},{"date":"2022-10-28","current":-1.464063,"twenty":-25.020946,"median":-2.452181,"eighty":-1.331555,"marketCap":432005442},{"date":"2022-11-04","current":-1.318774,"twenty":-24.880554,"median":-2.304152,"eighty":-1.330032,"marketCap":389134673},{"date":"2022-11-11","current":-1.402279,"twenty":-24.72355,"median":-2.205207,"eighty":-1.330032,"marketCap":392336643},{"date":"2022-11-18","current":-1.071185,"twenty":-24.116213,"median":-2.120061,"eighty":-1.321288,"marketCap":299701602},{"date":"2022-11-25","current":-0.833577,"twenty":-23.232604,"median":-2.052303,"eighty":-1.304144,"marketCap":233222338},{"date":"2022-12-02","current":-0.903691,"twenty":-22.029676,"median":-1.963408,"eighty":-1.287526,"marketCap":252839170},{"date":"2022-12-09","current":-0.771253,"twenty":-20.652703,"median":-1.869106,"eighty":-1.273678,"marketCap":215785153},{"date":"2022-12-16","current":-0.631026,"twenty":-20.24699,"median":-1.781428,"eighty":-1.254406,"marketCap":176551489},{"date":"2022-12-23","current":-0.662187,"twenty":-20.170872,"median":-1.761143,"eighty":-1.246835,"marketCap":185270081},{"date":"2022-12-30","current":-0.584283,"twenty":-19.910465,"median":-1.729267,"eighty":-1.233091,"marketCap":163473601},{"date":"2023-01-06","current":-0.646606,"twenty":-19.910465,"median":-1.709507,"eighty":-1.220425,"marketCap":180910785},{"date":"2023-01-13","current":-0.864739,"twenty":-19.727655,"median":-1.700287,"eighty":-1.204982,"marketCap":241940930},{"date":"2023-01-20","current":-0.705035,"twenty":-19.324279,"median":-1.696599,"eighty":-1.18418,"marketCap":197258145},{"date":"2023-01-27","current":-0.966014,"twenty":-19.073908,"median":-1.680001,"eighty":-1.168577,"marketCap":270276354},{"date":"2023-02-03","current":-0.817996,"twenty":-19.036154,"median":-1.663404,"eighty":-1.145789,"marketCap":228863042},{"date":"2023-02-10","current":-0.697244,"twenty":-18.849703,"median":-1.652339,"eighty":-1.126955,"marketCap":195078497},{"date":"2023-02-17","current":-0.759568,"twenty":-18.510377,"median":-1.599988,"eighty":-1.120876,"marketCap":212515681},{"date":"2023-02-24","current":-0.669978,"twenty":-18.137426,"median":-1.580986,"eighty":-1.092453,"marketCap":187449729},{"date":"2023-03-03","current":-0.681663,"twenty":-17.656234,"median":-1.570639,"eighty":-1.028927,"marketCap":190719201},{"date":"2023-03-10","current":-0.689454,"twenty":-15.84292,"median":-1.562021,"eighty":-1.00081,"marketCap":192898849},{"date":"2023-03-17","current":-0.588178,"twenty":-12.481002,"median":-1.538592,"eighty":-0.965462,"marketCap":164563425},{"date":"2023-03-24","current":-0.592742,"twenty":-10.968835,"median":-1.527779,"eighty":-0.894342,"marketCap":143038670},{"date":"2023-03-31","current":-0.54297,"twenty":-10.872382,"median":-1.517437,"eighty":-0.884215,"marketCap":131027790},{"date":"2023-04-06","current":-0.538445,"twenty":-10.810224,"median":-1.510673,"eighty":-0.88032,"marketCap":129935891},{"date":"2023-04-14","current":-0.534538,"twenty":-10.69448,"median":-1.497376,"eighty":-0.857727,"marketCap":128993146},{"date":"2023-04-21","current":-0.539068,"twenty":-10.424412,"median":-1.489775,"eighty":-0.829682,"marketCap":130086308},{"date":"2023-04-28","current":-0.511888,"twenty":-10.250797,"median":-1.484646,"eighty":-0.81488,"marketCap":123527335},{"date":"2023-05-05","current":-0.534538,"twenty":-10.004306,"median":-1.471564,"eighty":-0.788392,"marketCap":128993146},{"date":"2023-05-12","current":-0.888336,"twenty":-9.42023,"median":-1.465302,"eighty":-0.768137,"marketCap":156322203},{"date":"2023-05-19","current":-0.777692,"twenty":-7.308984,"median":-1.45367,"eighty":-0.771253,"marketCap":136852082},{"date":"2023-05-26","current":-0.914566,"twenty":-6.075459,"median":-1.441122,"eighty":-0.771297,"marketCap":160938049},{"date":"2023-06-02","current":-0.933231,"twenty":-5.771097,"median":-1.436569,"eighty":-0.771471,"marketCap":164222499},{"date":"2023-06-09","current":-0.839908,"twenty":-5.513889,"median":-1.428574,"eighty":-0.777692,"marketCap":147800249},{"date":"2023-06-16","current":-0.796357,"twenty":-5.358493,"median":-1.425167,"eighty":-0.783914,"marketCap":140136532},{"date":"2023-06-23","current":-0.659483,"twenty":-5.277043,"median":-1.40727,"eighty":-0.771253,"marketCap":116050565},{"date":"2023-06-30","current":-0.703034,"twenty":-5.076636,"median":-1.402434,"eighty":-0.766514,"marketCap":123714282},{"date":"2023-07-07","current":-0.696812,"twenty":-4.903021,"median":-1.400732,"eighty":-0.759568,"marketCap":122619465},{"date":"2023-07-14","current":-0.858572,"twenty":-4.803353,"median":-1.392762,"eighty":-0.759568,"marketCap":151084699},{"date":"2023-07-21","current":-0.902123,"twenty":-4.720832,"median":-1.38309,"eighty":-0.76184,"marketCap":158748415},{"date":"2023-07-28","current":-0.902123,"twenty":-4.548289,"median":-1.369067,"eighty":-0.766093,"marketCap":158748415},{"date":"2023-08-04","current":-0.920788,"twenty":-4.339308,"median":-1.356759,"eighty":-0.767358,"marketCap":162032865},{"date":"2023-08-11","current":-0.964339,"twenty":-4.226779,"median":-1.354805,"eighty":-0.768916,"marketCap":169696582},{"date":"2023-08-18","current":-1.071184,"twenty":-4.212847,"median":-1.341126,"eighty":-0.771253,"marketCap":187682117},{"date":"2023-08-25","current":-1.115033,"twenty":-4.206417,"median":-1.331904,"eighty":-0.77134,"marketCap":195365010},{"date":"2023-09-01","current":-1.165147,"twenty":-4.187126,"median":-1.325058,"eighty":-0.771471,"marketCap":204145460},{"date":"2023-09-08","current":-1.108769,"twenty":-4.137828,"median":-1.318774,"eighty":-0.772715,"marketCap":194267454},{"date":"2023-09-15","current":-1.102505,"twenty":-4.046734,"median":-1.300575,"eighty":-0.778936,"marketCap":193169898},{"date":"2023-09-22","current":-1.039863,"twenty":-3.993149,"median":-1.292152,"eighty":-0.783914,"marketCap":182194335},{"date":"2023-09-29","current":-1.108769,"twenty":-3.92456,"median":-1.28265,"eighty":-0.784498,"marketCap":194267454},{"date":"2023-10-06","current":-1.02107,"twenty":-3.890266,"median":-1.27286,"eighty":-0.788392,"marketCap":178901667},{"date":"2023-10-13","current":-1.033598,"twenty":-3.885979,"median":-1.257306,"eighty":-0.794625,"marketCap":181096779},{"date":"2023-10-20","current":-0.989749,"twenty":-3.864545,"median":-1.253862,"eighty":-0.794971,"marketCap":173413885},{"date":"2023-10-27","current":-1.039863,"twenty":-3.855972,"median":-1.250062,"eighty":-0.795664,"marketCap":182194335},{"date":"2023-11-03","current":-0.970956,"twenty":-3.824892,"median":-1.24107,"eighty":-0.80009,"marketCap":170121217},{"date":"2023-11-10","current":-0.876993,"twenty":-3.803458,"median":-1.233091,"eighty":-0.803649,"marketCap":153657873},{"date":"2023-11-17","current":-0.974107,"twenty":-3.770235,"median":-1.223778,"eighty":-0.807025,"marketCap":165172440},{"date":"2023-11-24","current":-0.967613,"twenty":-3.727368,"median":-1.213951,"eighty":-0.8088,"marketCap":164071290},{"date":"2023-12-01","current":-0.993589,"twenty":-3.668424,"median":-1.20606,"eighty":-0.8088,"marketCap":168475888},{"date":"2023-12-08","current":-1.097493,"twenty":-3.624484,"median":-1.192112,"eighty":-0.81092,"marketCap":186094282},{"date":"2023-12-15","current":-1.116976,"twenty":-3.600907,"median":-1.17787,"eighty":-0.815659,"marketCap":189397731},{"date":"2023-12-22","current":-2.435267,"twenty":-3.563398,"median":-1.186164,"eighty":-0.817996,"marketCap":412931100},{"date":"2023-12-29","current":-2.545665,"twenty":-3.531247,"median":-1.195838,"eighty":-0.817996,"marketCap":431650643},{"date":"2024-01-05","current":-2.435267,"twenty":-3.511956,"median":-1.203364,"eighty":-0.820333,"marketCap":412931100},{"date":"2024-01-12","current":-2.688534,"twenty":-3.495881,"median":-1.213437,"eighty":-0.826566,"marketCap":455875934},{"date":"2024-01-19","current":-2.883356,"twenty":-3.48945,"median":-1.221915,"eighty":-0.829682,"marketCap":488910422},{"date":"2024-01-26","current":-2.876862,"twenty":-3.47659,"median":-1.233091,"eighty":-0.83124,"marketCap":487809272},{"date":"2024-02-02","current":-3.117141,"twenty":-3.460515,"median":-1.235593,"eighty":-0.833621,"marketCap":528551808},{"date":"2024-02-09","current":-3.272998,"twenty":-3.448726,"median":-1.249027,"eighty":-0.836175,"marketCap":554979398},{"date":"2024-02-16","current":-2.88069,"twenty":-3.448726,"median":-1.254147,"eighty":-0.839908,"marketCap":488458412},{"date":"2024-02-23","current":-2.831627,"twenty":-3.444439,"median":-1.259169,"eighty":-0.842397,"marketCap":480139169},{"date":"2024-03-01","current":-2.754528,"twenty":-3.436937,"median":-1.274905,"eighty":-0.852491,"marketCap":467066072},{"date":"2024-03-08","current":-2.670421,"twenty":-3.41979,"median":-1.284551,"eighty":-0.853832,"marketCap":452804513},{"date":"2024-03-15","current":-2.558277,"twenty":-3.401571,"median":-1.29463,"eighty":-0.857273,"marketCap":433789100},{"date":"2024-03-22","current":-2.165774,"twenty":-3.391926,"median":-1.301003,"eighty":-0.858572,"marketCap":367235156},{"date":"2024-03-28","current":-2.393164,"twenty":-3.370492,"median":-1.318774,"eighty":-0.858572,"marketCap":475385316},{"date":"2024-04-05","current":-2.148639,"twenty":-3.311549,"median":-1.327504,"eighty":-0.860844,"marketCap":426812003},{"date":"2024-04-12","current":-1.833545,"twenty":-3.311549,"median":-1.333653,"eighty":-0.864739,"marketCap":364220857},{"date":"2024-04-19","current":-1.410419,"twenty":-3.279398,"median":-1.341342,"eighty":-0.864794,"marketCap":280169890},{"date":"2024-04-26","current":-1.242369,"twenty":-3.274039,"median":-1.341126,"eighty":-0.864794,"marketCap":246787946},{"date":"2024-05-03","current":-1.422423,"twenty":-3.272998,"median":-1.339441,"eighty":-0.864794,"marketCap":282554315},{"date":"2024-05-10","current":-1.452432,"twenty":-3.268681,"median":-1.354074,"eighty":-0.871015,"marketCap":288515376},{"date":"2024-05-17","current":-1.412314,"twenty":-3.26001,"median":-1.355782,"eighty":-0.876993,"marketCap":292092013},{"date":"2024-05-24","current":-1.158674,"twenty":-3.225813,"median":-1.354074,"eighty":-0.877237,"marketCap":239634672},{"date":"2024-05-31","current":-1.043383,"twenty":-3.211609,"median":-1.341126,"eighty":-0.879703,"marketCap":215790426},{"date":"2024-06-07","current":-1.009596,"twenty":-3.192472,"median":-1.333025,"eighty":-0.88032,"marketCap":208802627},{"date":"2024-06-14","current":-0.98075,"twenty":-3.181982,"median":-1.330053,"eighty":-0.88032,"marketCap":202836837},{"date":"2024-06-21","current":-0.755755,"twenty":-3.174189,"median":-1.321916,"eighty":-0.87847,"marketCap":156303680},{"date":"2024-06-28","current":-0.692294,"twenty":-3.170792,"median":-1.318774,"eighty":-0.877188,"marketCap":143178944},{"date":"2024-07-05","current":-0.634603,"twenty":-3.142038,"median":-1.315549,"eighty":-0.864794,"marketCap":131247365},{"date":"2024-07-12","current":-0.674987,"twenty":-3.119885,"median":-1.301003,"eighty":-0.859935,"marketCap":139599470},{"date":"2024-07-15","current":-0.686525,"twenty":-3.118513,"median":-1.300575,"eighty":-0.858572,"marketCap":141985786},{"date":"2024-08-02","current":-0.68941,"twenty":-3.117141,"median":-1.300147,"eighty":-0.858572,"marketCap":142582365},{"date":"2024-08-09","current":-0.605758,"twenty":-3.097659,"median":-1.294588,"eighty":-0.848061,"marketCap":125281576},{"date":"2024-08-16","current":-0.60941,"twenty":-3.065189,"median":-1.28637,"eighty":-0.833577,"marketCap":124220340},{"date":"2024-08-23","current":-0.514541,"twenty":-3.055914,"median":-1.279565,"eighty":-0.817996,"marketCap":104882577},{"date":"2024-08-30","current":-0.517764,"twenty":-3.054341,"median":-1.273965,"eighty":-0.8088,"marketCap":105539512},{"date":"2024-09-06","current":-0.498896,"twenty":-3.052629,"median":-1.268761,"eighty":-0.804006,"marketCap":101693459},{"date":"2024-09-13","current":-0.673867,"twenty":-3.052201,"median":-1.254795,"eighty":-0.793067,"marketCap":137359030},{"date":"2024-09-20","current":-0.714885,"twenty":-3.043957,"median":-1.250062,"eighty":-0.776448,"marketCap":145720014},{"date":"2024-09-27","current":-0.60941,"twenty":-3.030682,"median":-1.247269,"eighty":-0.770474,"marketCap":124220340},{"date":"2024-10-04","current":-0.562884,"twenty":-3.005449,"median":-1.242369,"eighty":-0.759568,"marketCap":114736595},{"date":"2024-10-11","current":-0.529894,"twenty":-2.97914,"median":-1.234118,"eighty":-0.750739,"marketCap":108011974},{"date":"2024-10-18","current":-0.61527,"twenty":-2.95253,"median":-1.22564,"eighty":-0.739313,"marketCap":125414766},{"date":"2024-10-25","current":-0.57935,"twenty":-2.944451,"median":-1.213951,"eighty":-0.734142,"marketCap":118092933},{"date":"2024-10-31","current":-0.533292,"twenty":-2.934797,"median":-1.206537,"eighty":-0.729185,"marketCap":108704742},{"date":"2024-11-08","current":-0.585971,"twenty":-2.925172,"median":-1.195838,"eighty":-0.709709,"marketCap":119442635},{"date":"2024-11-15","current":-0.419997,"twenty":-2.922744,"median":-1.180905,"eighty":-0.703113,"marketCap":94556475},{"date":"2024-11-22","current":-0.371808,"twenty":-2.92249,"median":-1.17407,"eighty":-0.697071,"marketCap":83707301},{"date":"2024-11-29","current":-0.37117,"twenty":-2.91193,"median":-1.166035,"eighty":-0.69059,"marketCap":83563762},{"date":"2024-12-06","current":-0.303269,"twenty":-2.891149,"median":-1.165147,"eighty":-0.68557,"marketCap":68276832},{"date":"2024-12-13","current":-0.308104,"twenty":-2.88229,"median":-1.162672,"eighty":-0.679326,"marketCap":69365338},{"date":"2024-12-20","current":-0.228302,"twenty":-2.879159,"median":-1.158778,"eighty":-0.673873,"marketCap":51399010},{"date":"2024-12-27","current":-0.281805,"twenty":-2.876862,"median":-1.150014,"eighty":-0.673867,"marketCap":63444344},{"date":"2025-01-03","current":-0.255027,"twenty":-2.876862,"median":-1.146355,"eighty":-0.669978,"marketCap":57415696},{"date":"2025-01-10","current":-0.245198,"twenty":-2.874317,"median":-1.138593,"eighty":-0.663197,"marketCap":55202800},{"date":"2025-01-17","current":-0.233403,"twenty":-2.868171,"median":-1.132275,"eighty":-0.656796,"marketCap":52547324},{"date":"2025-01-24","current":-0.222245,"twenty":-2.85831,"median":-1.128781,"eighty":-0.646866,"marketCap":50035387},{"date":"2025-01-31","current":-0.207209,"twenty":-2.840038,"median":-1.124676,"eighty":-0.643039,"marketCap":46650253},{"date":"2025-02-07","current":-1.051985,"twenty":-2.823791,"median":-1.121298,"eighty":-0.64111,"marketCap":236839749},{"date":"2025-02-14","current":-0.733202,"twenty":-2.818476,"median":-1.120876,"eighty":-0.643039,"marketCap":165070128},{"date":"2025-02-21","current":-0.64288,"twenty":-2.812485,"median":-1.118477,"eighty":-0.643031,"marketCap":144735402},{"date":"2025-02-28","current":-0.658819,"twenty":-2.803591,"median":-1.116976,"eighty":-0.644411,"marketCap":148323883},{"date":"2025-03-07","current":-0.547245,"twenty":-2.801008,"median":-1.110663,"eighty":-0.636245,"marketCap":123204516},{"date":"2025-03-14","current":-0.431473,"twenty":-2.796913,"median":-1.108769,"eighty":-0.631096,"marketCap":97140182},{"date":"2025-03-21","current":-0.521427,"twenty":-2.792516,"median":-1.102505,"eighty":-0.62713,"marketCap":88603523},{"date":"2025-03-28","current":-0.43064,"twenty":-2.784875,"median":-1.097493,"eighty":-0.619015,"marketCap":73176481},{"date":"2025-04-04","current":-0.388282,"twenty":-2.77135,"median":-1.096241,"eighty":-0.613037,"marketCap":65978794},{"date":"2025-04-11","current":-0.356513,"twenty":-2.754107,"median":-1.09048,"eighty":-0.611536,"marketCap":60580529},{"date":"2025-04-17","current":-0.332722,"twenty":-2.752176,"median":-1.083864,"eighty":-0.609696,"marketCap":56537829},{"date":"2025-04-25","current":-0.471868,"twenty":-2.738793,"median":-1.080862,"eighty":-0.606488,"marketCap":80182229},{"date":"2025-05-02","current":-0.428663,"twenty":-2.703896,"median":-1.071184,"eighty":-0.598126,"marketCap":72840589},{"date":"2025-05-09","current":-0.416521,"twenty":-2.69425,"median":-1.060024,"eighty":-0.594913,"marketCap":70777252},{"date":"2025-05-16","current":-0.591746,"twenty":-2.689677,"median":-1.057662,"eighty":-0.591763,"marketCap":84452857},{"date":"2025-05-23","current":-0.639237,"twenty":-2.687748,"median":-1.049056,"eighty":-0.592013,"marketCap":91230678},{"date":"2025-05-30","current":-0.712617,"twenty":-2.684605,"median":-1.046127,"eighty":-0.592742,"marketCap":101703313},{"date":"2025-06-06","current":-0.777592,"twenty":-2.679246,"median":-1.043383,"eighty":-0.594219,"marketCap":110976332},{"date":"2025-06-13","current":-0.711777,"twenty":-2.677429,"median":-1.039863,"eighty":-0.597691,"marketCap":101583351},{"date":"2025-06-20","current":-0.629571,"twenty":-2.675923,"median":-1.039153,"eighty":-0.597691,"marketCap":89851122},{"date":"2025-06-27","current":-0.671514,"twenty":-2.67422,"median":-1.033598,"eighty":-0.596997,"marketCap":95837198},{"date":"2025-07-03","current":-0.617887,"twenty":-2.671808,"median":-1.033598,"eighty":-0.597691,"marketCap":88183658},{"date":"2025-07-11","current":-0.626545,"twenty":-2.667044,"median":-1.033598,"eighty":-0.597691,"marketCap":89419261},{"date":"2025-07-18","current":-0.606624,"twenty":-2.663819,"median":-1.033486,"eighty":-0.596302,"marketCap":86576174},{"date":"2025-07-25","current":-0.680845,"twenty":-2.662803,"median":-1.027334,"eighty":-0.597691,"marketCap":97168770},{"date":"2025-08-01","current":-0.583341,"twenty":-2.658865,"median":-1.025887,"eighty":-0.597691,"marketCap":83253242},{"date":"2025-08-08","current":-0.633438,"twenty":-2.628925,"median":-1.018217,"eighty":-0.597691,"marketCap":90402944},{"date":"2025-08-15","current":-0.671851,"twenty":-2.608646,"median":-1.01456,"eighty":-0.597691,"marketCap":95885182},{"date":"2025-08-22","current":-0.57589,"twenty":-2.594724,"median":-1.009192,"eighty":-0.597691,"marketCap":63423389},{"date":"2025-08-29","current":-1.752501,"twenty":-2.586313,"median":-1.009596,"eighty":-0.598995,"marketCap":193004672},{"date":"2025-09-05","current":-1.765777,"twenty":-2.577902,"median":-1.01456,"eighty":-0.600315,"marketCap":194466829},{"date":"2025-09-12","current":-2.17735,"twenty":-2.562482,"median":-1.018217,"eighty":-0.601664,"marketCap":239793684},{"date":"2025-09-19","current":-2.212754,"twenty":-2.555269,"median":-1.025887,"eighty":-0.603107,"marketCap":243692768},{"date":"2025-09-26","current":-2.018031,"twenty":-2.548721,"median":-1.027334,"eighty":-0.604535,"marketCap":222247805},{"date":"2025-10-03","current":-2.159648,"twenty":-2.542299,"median":-1.033486,"eighty":-0.605723,"marketCap":237844142},{"date":"2025-10-10","current":-3.345683,"twenty":-2.555269,"median":-1.033598,"eighty":-0.605758,"marketCap":368463466},{"date":"2025-10-17","current":-3.407002,"twenty":-2.598929,"median":-1.033598,"eighty":-0.605936,"marketCap":375216537},{"date":"2025-10-24","current":-3.776905,"twenty":-2.662926,"median":-1.033598,"eighty":-0.606372,"marketCap":415954333},{"date":"2025-10-31","current":-3.640625,"twenty":-2.674883,"median":-1.039863,"eighty":-0.607081,"marketCap":400945671},{"date":"2025-11-07","current":-5.515862,"twenty":-2.686962,"median":-1.039863,"eighty":-0.608117,"marketCap":330190553},{"date":"2025-11-14","current":-6.892977,"twenty":-2.717777,"median":-1.044211,"eighty":-0.608949,"marketCap":412627416},{"date":"2025-11-21","current":-9.34641,"twenty":-2.77135,"median":-1.046127,"eighty":-0.60941,"marketCap":559494801},{"date":"2025-11-28","current":-9.46324,"twenty":-2.797023,"median":-1.052188,"eighty":-0.60941,"marketCap":566488486},{"date":"2025-12-05","current":-8.645429,"twenty":-2.818537,"median":-1.058529,"eighty":-0.60941,"marketCap":517532691},{"date":"2025-12-12","current":-9.268523,"twenty":-2.872304,"median":-1.063219,"eighty":-0.60966,"marketCap":554832344},{"date":"2025-12-19","current":-8.918033,"twenty":-2.882823,"median":-1.071185,"eighty":-0.610693,"marketCap":533851289},{"date":"2025-12-26","current":-10.943088,"twenty":-2.903133,"median":-1.083712,"eighty":-0.610827,"marketCap":655075163},{"date":"2026-01-02","current":-9.619014,"twenty":-2.923958,"median":-1.083864,"eighty":-0.610838,"marketCap":575813399},{"date":"2026-01-09","current":-11.619697,"twenty":-2.97914,"median":-1.092947,"eighty":-0.610897,"marketCap":695578313},{"date":"2026-01-16","current":-11.493909,"twenty":-3.052201,"median":-1.096241,"eighty":-0.611404,"marketCap":688048360},{"date":"2026-01-23","current":-10.410466,"twenty":-3.059624,"median":-1.097493,"eighty":-0.611527,"marketCap":623191342},{"date":"2026-01-30","current":-8.714644,"twenty":-3.119885,"median":-1.102505,"eighty":-0.61154,"marketCap":521676011},{"date":"2026-02-06","current":-8.055157,"twenty":-3.175062,"median":-1.108769,"eighty":-0.611549,"marketCap":482197826},{"date":"2026-02-13","current":-7.207246,"twenty":-3.239492,"median":-1.110663,"eighty":-0.611549,"marketCap":431440160},{"date":"2026-02-20","current":-7.584095,"twenty":-3.273623,"median":-1.116004,"eighty":-0.611549,"marketCap":453999123},{"date":"2026-02-27","current":-8.008051,"twenty":-3.321408,"median":-1.117077,"eighty":-0.611697,"marketCap":479377956},{"date":"2026-03-06","current":-9.347815,"twenty":-3.393384,"median":-1.120876,"eighty":-0.61326,"marketCap":490657437},{"date":"2026-03-13","current":-9.690993,"twenty":-3.417247,"median":-1.121298,"eighty":-0.61527,"marketCap":508670512},{"date":"2026-03-20","current":-7.806633,"twenty":-3.448726,"median":-1.124676,"eighty":-0.615376,"marketCap":409762357}],"updateTime":1774169372373},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVVD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2617154496","title":"Invivyd reports cash, cash equivalents of $226.7M as of December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2617154496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617154496?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:20","pubTimestamp":1772713254,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents were $226.7 million as of December 31, 2025. In the second half of 2025, Invivyd (IVVD) secured over $200 million of capi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-reports-cash-cash-equivalents-of-226-7m-as-of-december-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-reports-cash-cash-equivalents-of-226-7m-as-of-december-31-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2617449935","title":"Invivyd appoints Michael Mina as CMO","url":"https://stock-news.laohu8.com/highlight/detail?id=2617449935","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617449935?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:20","pubTimestamp":1772713237,"startTime":"0","endTime":"0","summary":"Invivyd (IVVD) announced the appointment of Michael Mina, M.D., Ph.D., as Chief Medical Officer. Mina is a former assistant professor at the Harvar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/invivyd-appoints-michael-mina-as-cmo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/invivyd-appoints-michael-mina-as-cmo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2617054435","title":"Invivyd FY revenue rises; operating expenses cut sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=2617054435","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617054435?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:17","pubTimestamp":1772713071,"startTime":"0","endTime":"0","summary":"Invivyd FY revenue rises; operating expenses cut sharplyOverviewBiopharmaceutical company reported Q4 PEMGARDA net product revenue up 25% yr/yrLoss per share for 2025 beat analyst expectationsNet loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL1N3ZT0KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2617541127","title":"BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541127","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541127?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712225,"startTime":"0","endTime":"0","summary":"BRIEF-Invivyd FY EPS USD -0.3 Vs. IBES Estimate USD -0.39\n\n\nMar 05 (Reuters) - Invivyd FY revenue USD 53.426 million.\n\nFY net income USD -52.489 million vs. IBES estimate USD -57.8 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX537BEB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2617541233","title":"Invivyd Q4 net product revenue rises 31% to USD 17.2 million in Q4 2025 earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541233","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541233?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712225,"startTime":"0","endTime":"0","summary":"Invivyd said Q4 2025 net product revenue from PEMGARDA was USD 17.2 million, up 25% YoY and 31% QoQ. For FY 2025, PEMGARDA net product revenue was USD 53.4 million. The company reported a FY 2025 net loss of USD 52.5 million, or USD 0.30 per share, and ended 2025 with cash and cash equivalents of USD 226.7 million after raising over USD 200 million in 2H 2025. FY 2025 R&D expenses were USD 38.3 million and SG&A expenses were USD 66.9 million. On business updates, Invivyd said its DECLARATION Phase 3 pivotal trial of VYD2311 to prevent COVID is fully enrolled, with top-line data expected mid-2026; the FDA granted Fast Track designation for VYD2311 in December 2025. The trial’s IDMC recommended allowing enrollment of pregnant and breastfeeding women, removed contraception requirements for women of childbearing age, and said certain protocol-specified safety visits are no longer required. The company also said it received FDA advice on the LIBERTY Phase 3 trial comparing VYD2311 with mRNA","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLxmvzL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IVVD","SG9999014005.SGD","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","BK4112","BK4139","LU2210149790.SGD","NDAQ","SG9999014021.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4539"],"gpt_icon":0},{"id":"2617411415","title":"Invivyd Names Michael Mina Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2617411415","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617411415?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712195,"startTime":"0","endTime":"0","summary":"Invivyd Inc. appointed Michael Mina, M.D., Ph.D. as its Chief Medical Officer. Mina previously served as an assistant professor at the Harvard T.H. Chan School of Public Health, Harvard Medical School, and Brigham and Women’s Hospital, and has held chief science or chief medical officer roles at diagnostics and digital health companies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL22FHgb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","IE00B64PRP62.GBP","NDAQ","BK4585","BK4139","SG9999014013.SGD","IVVD","LU0314104364.USD","LU2095319765.USD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","BK4539"],"gpt_icon":0},{"id":"2617541180","title":"Invivyd FY Net Income USD -52.489 Million VS. Ibes Estimate USD -57.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541180?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712180,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nPLX537BEB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"2617411295","title":"Press Release: Invivyd Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Recent Business Highlights and DECLARATION Clinical Trial Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2617411295","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617411295?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:03","pubTimestamp":1772712180,"startTime":"0","endTime":"0","summary":"-- Achieved Q4 2025 PEMGARDA  net product revenue of $17.2. million, representing 25% growth year-over-year and 31% growth. -- 2025 year-end cash and cash equivalents of $226.7 million after raising. over $200 million from financing transactions in 2H 2025. -- Announced initiation of DECLARATION Phase 3 pivotal clinical trial of. vaccine-alternative antibody VYD2311 to prevent COVID, with top-line data. expected mid-2026; Fast Track designation for VYD2311 granted by FDA in. prespecified review of unblinded VYD2311 safety data resulted in IDMC. recommendation to allow enrollment of pregnant and breastfeeding women in. \"With potential commercialization of VYD2311 on the horizon, we are encouraged by continued commercial execution and appeal for monoclonal antibody prophylaxis demonstrated by revenue of PEMGARDA  more than doubling year over year, while operating expenses were reduced by nearly half,\" noted Bill Duke, Chief Financial Officer of Invivyd. \"While we are pleased with Invivyd","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","IVVD","BK4539","R","BK4232","BK4139"],"gpt_icon":0},{"id":"2617987541","title":"Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2617987541","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617987541?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712060,"startTime":"0","endTime":"0","summary":"-- Former assistant professor of epidemiology, immunology, and infectious. disease at the Harvard T.H. Chan School of Public Health and pathology at. Harvard Medical School and Brigham and Women's Hospital, Dr. Mina. -- Dr. Mina's research at Harvard focused on antibodies, vaccines, and. other diseases, and will be a significant asset to Invivyd and the. Dr. Mina is a former assistant professor at the Harvard T.H. Chan School of Public Health, Harvard Medical School and Brigham and Women's Hospital, and he has served as chief science or chief medical officer at several diagnostics and digital health companies. Dr. Mina rose to prominence during the COVID pandemic advising the U.S. federal and international governments on testing policies and advocating that the U.S. shift its public health goal from attempting to diagnose every COVID case, to identifying who was contagious at the moment in order to reduce transmission and accelerate reopening society. Dr. Mina helped lead the U.S. gove","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Invivyd Appoints Distinguished Physician and Scientist, Michael Mina, M.D., Ph.D. as Chief Medical Officer","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","IVVD"],"gpt_icon":0},{"id":"2616323627","title":"Invivyd Inc  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323627","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323627?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:39","pubTimestamp":1772545146,"startTime":"0","endTime":"0","summary":"Invivyd Inc  expected to post a loss of8cents a share - Earnings Preview Invivyd Inc IVVD.OQ IVVD.O is expected to  show a rise in quarterly revenue when it reports  results on March 5 for the period ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL8N3ZR1PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4139","BK4539"],"gpt_icon":0},{"id":"2616366693","title":"Invivyd Grants 192,000 Inducement Stock Options to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2616366693","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616366693?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:01","pubTimestamp":1772485270,"startTime":"0","endTime":"0","summary":"Invivyd said it granted stock options to four newly hired non-executive employees covering a total of 192,000 shares. The options have an exercise price of $1.69 per share, vest over four years with 25% vesting after one year and the remainder vesting monthly thereafter, and have a 10-year term.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL3jVNCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","BK4585","LU2210150020.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4112","IE00B64PRP62.GBP","IVVD","SG9999014005.SGD","SG9999014013.SGD","BK4588","NDAQ","SG9999014039.USD"],"gpt_icon":0},{"id":"2614043338","title":"Invivyd Price Target Maintained With a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2614043338","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614043338?lang=en_us&edition=fundamental","pubTime":"2026-02-26 19:37","pubTimestamp":1772105820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVVD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 26, 2026 06:37 ET (11:37 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IVVD","BK4139"],"gpt_icon":0},{"id":"2614069324","title":"Analysts Offer Insights on Healthcare Companies: US Physical Therapy (USPH) and Invivyd (IVVD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069324","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069324?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:10","pubTimestamp":1772068209,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on US Physical Therapy (USPH – Research Report) and Invivyd (IVVD – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-us-physical-therapy-usph-and-invivyd-ivvd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-us-physical-therapy-usph-and-invivyd-ivvd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4137","BK4539","IVVD","LU0106261612.USD","LU0128526141.USD","XBI","BK4585","HCSG","USPH","BK4185","XLV","LU0029874061.USD","BK4581","LU0012050646.USD","LABU"],"gpt_icon":0},{"id":"2613157007","title":"Invivyd Study Links Pemivibart Serum Levels to Variant-Agnostic COVID-19 Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=2613157007","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613157007?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:05","pubTimestamp":1771934703,"startTime":"0","endTime":"0","summary":"Invivyd Inc. announced a peer-reviewed publication in Infectious Diseases and Therapy describing a statistical immune correlate-of-protection model for its COVID-19 monoclonal antibody pemivibart, based on data from the CANOPY Phase 3 pivotal clinical trial. The analysis reports a relationship between serum monoclonal antibody activity levels and clinical protection against symptomatic COVID-19 across multiple Omicron variants in a seropositive population, and is intended to support immunobridging assessments for related antibodies. The results have already been published.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLw52Mw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","LU2095319765.USD","SG9999014039.USD","BK4585","IVVD","BK4588","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014005.SGD","NDAQ","IE00B3QW5Z07.USD","SG9999014013.SGD","BK4539","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2608487025","title":"Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608487025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608487025?lang=en_us&edition=fundamental","pubTime":"2026-02-03 23:02","pubTimestamp":1770130920,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Invivyd (IVVD – Research Report) and Pfizer (PFE –...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-invivyd-ivvd-and-pfizer-pfe-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-invivyd-ivvd-and-pfizer-pfe-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","IE00BLSP4452.SGD","BK4568","LU0985481810.HKD","IE00BLSP4239.USD","IE0002270589.USD","LU1894683348.USD","XBI","BK4139","SGXZ57979304.SGD","LU1883839398.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999013999.USD","LABU","LU1057294990.SGD","LU0321505439.SGD","LU0321505868.SGD","BK4581","BK4592","SG9999001176.SGD","BK4550","SG9999002224.SGD","LU0289739699.SGD","LU0170899867.USD","BK4588","BK4585","LU1894683264.USD","SG9999011175.SGD","BK4599","BK4539","LU0456855351.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4534","LU0029874061.USD","LU0122379950.USD","BK4533","IE000M9KFDE8.USD","LU0306806265.USD","BK4137","SG9999003800.SGD","LU0058720904.USD","IVVD","LU0128526141.USD","LU0225771236.USD","LU0306807586.USD","LU1066051498.USD","PFE","LU0225284248.USD","LU0234572021.USD","SG9999002232.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4007"],"gpt_icon":0},{"id":"2608487037","title":"Invivyd Reaches Alignment With US FDA on Phase 3 Trial of VYD2311 for COVID Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2608487037","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608487037?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:42","pubTimestamp":1770129763,"startTime":"0","endTime":"0","summary":"Invivyd (IVVD) said Tuesday it has achieved alignment with the US Food and Drug Administration for a phase 3 trial to evaluate the safety and immunologic profile of its VYD2311 investigational antibod","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4539","IVVD"],"gpt_icon":0},{"id":"2608787246","title":"BUZZ-U.S. STOCKS ON THE MOVE-JetBlue, VSE, Walt Disney","url":"https://stock-news.laohu8.com/highlight/detail?id=2608787246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608787246?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:17","pubTimestamp":1770128229,"startTime":"0","endTime":"0","summary":"** Palantir Technologies Inc PLTR.O:BUZZ - Jumps as US government contracts boost quarterly sales nL4N3YZ0PE** Merck & Co Inc MRK.N:BUZZ - Falls on downbeat 2026 profit and sales forecasts nL4N3YZ0U8     ** Newmont Corp NEM.N:     ** Gold Fields Ltd GFI.N:** AngloGold Ashanti PLC AU.N: ** Harmony Gold Mining Co Ltd HMY.N:BUZZ - Gold, silver miners gain as metal prices edge higher after two-session rout nL4N3YZ0ST** McDonald's Corp MCD.N:BUZZ - Up after brokerage BTIG upgrades to 'buy'  nL6N3YY0WK** SoFi Technologies Inc SOFI.O:BUZZ - Rises after J.P. Morgan upgrades to 'overweight' nL6N3YZ0MY     ** Rio Tinto PLC RIO.N:              ** BHP Group Ltd BHP.N:** Southern Copper Corp SCCO.N: ** Freeport-McMoRan Inc FCX.N:BUZZ - Copper miners rise on China stockpiling, stronger risk sentiment nL4N3YZ0W3** PepsiCo Inc PEP.O:BUZZ - Falls after reaffirming annual earnings forecast despite Q4 revenue beat nL4N3YZ0YH** FedEx Corp FDX.N:BUZZ - Gains after Bernstein upgrades rating to 'outperform' ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL6N3YZ0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOFX","PLTZ","ADM","GTBP","FDX","PYPG","PLTA","ETN","LU1162221912.USD","MCD","LU1223082196.USD","OVV","RARE","MRK","DIS","NEM","PLTD","JBLU","PYPY","PLTG","BK4559","LU1066051225.USD","PLTW","PLT","PLOO","PEP","RIO.AU","EVR","PLTY","BHP.AU","SCNX","BALL","DVA","VSEC","IVVD","RIO.UK","PTIR","AU","WST","MPC","HPQ","SOC","PLYY","PLTU"],"gpt_icon":1},{"id":"2608730708","title":"BUZZ-Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2608730708","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608730708?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:13","pubTimestamp":1770120821,"startTime":"0","endTime":"0","summary":"BUZZ-Invivyd rises on late-stage trial testing COVID antibody against mRNA vaccines** Shares of drug developer Invivyd IVVD.O rise 5.17% to $1.83 premarket ** Co says it has launched a late-stage trial testing its experimental COVID antibody VYD2311 against mRNA vaccines** Says study will enroll ~210 people and compare safety; adds that it will also test using the antibody and vaccines together** Says FDA asked it to closely track heart inflammation, a rare side effect previously seen after mRNA vaccinations** Adds VYD2311 is a single-shot antibody designed to protect against current COVID variants; uses same platform as IVVD drug that was cleared earlier** Shares rose ~457% in 2025","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4N3YZ142:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVVD","BK4539","BK4139"],"gpt_icon":0},{"id":"2608671873","title":"Invivyd Aligns With the U.S. FDA on Liberty, a Phase 3 Trial to Evaluate the Safety of Vyd2311 Antibody Versus Mrna Covid Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2608671873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608671873?lang=en_us&edition=fundamental","pubTime":"2026-02-03 20:01","pubTimestamp":1770120060,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA1MFFRV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVVD","BK4539"],"gpt_icon":0},{"id":"2606015734","title":"Institutional investors in Invivyd, Inc. (NASDAQ:IVVD) see US$113m decrease in market cap last week, although long-term gains have benefitted them.","url":"https://stock-news.laohu8.com/highlight/detail?id=2606015734","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606015734?lang=en_us&edition=fundamental","pubTime":"2026-01-27 23:56","pubTimestamp":1769529386,"startTime":"0","endTime":"0","summary":"Key Insights Institutions' substantial holdings in Invivyd implies that they have significant influence over the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/institutional-investors-in-invivyd-inc-nasdaqivvd-see-us113m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ivvd/invivyd/news/institutional-investors-in-invivyd-inc-nasdaqivvd-see-us113m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NQmain","JEPQ","QYLG","PSQ","USAW.SI","BK4139","QYLD","NVIW.SI","QLD","USJW.SI","BK4539","MNQmain","QQQE","QID","QQQJ","GPIQ","IVVD","QQQY","SQQQ","TSYW.SI",".IXIC","TQQQ","QQQM"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":92,"code":"91000000","status":"200"}]}}